Related Experiment Video
Updated: Jul 23, 2025

Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
Published on: June 9, 2017
Inhibition of nucleolar transcription by oxaliplatin involves ATM/ATR kinase signaling
Misha Nechay1, Danyang Wang1, Ralph E Kleiner1
1Department of Chemistry, Princeton University, Princeton, NJ 08544, USA.
Abstract:
Platinum (Pt) compounds are an important class of anti-cancer therapeutics, but outstanding questions remain regarding their mechanism of action. Here, we demonstrate that oxaliplatin, a Pt drug used to treat colorectal cancer, inhibits rRNA transcription through ATM and ATR signaling, and induces DNA damage and nucleolar disruption. We show that oxaliplatin causes nucleolar accumulation of the nucleolar DNA damage response proteins (n-DDR) NBS1 and TOPBP1; however transcriptional inhibition does not depend upon NBS1 or TOPBP1, nor does oxaliplatin induce substantial amounts of nucleolar DNA damage, distinguishing the nucleolar response from previously characterized n-DDR pathways. Taken together, our work indicates that oxaliplatin induces a distinct ATM and ATR signaling pathway that functions to inhibit Pol I transcription in the absence of direct nucleolar DNA damage, demonstrating how nucleolar stress and transcriptional silencing can be linked to DNA damage signaling and highlighting an important mechanism of Pt drug cytotoxicity.
Insights
Oxaliplatin, a platinum drug for colorectal cancer, inhibits rRNA transcription by disrupting the nucleolus via ATM/ATR signaling. This distinct pathway silences transcription without direct DNA damage, revealing a key mechanism of platinum drug toxicity.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Platinum (Pt) compounds are crucial anti-cancer drugs.
- The precise mechanisms of Pt drug action, particularly oxaliplatin, require further elucidation.
- Understanding oxaliplatin's effects on rRNA transcription and nucleolar function is key to its therapeutic application.
Purpose of the Study:
- To investigate the mechanism by which oxaliplatin inhibits rRNA transcription.
- To determine the role of ATM and ATR signaling in oxaliplatin's effects.
- To clarify the relationship between nucleolar disruption, DNA damage signaling, and transcriptional inhibition by oxaliplatin.
Main Methods:
- Treatment of cells with oxaliplatin.
- Analysis of rRNA transcription rates.
- Assessment of ATM and ATR signaling pathway activation.
- Investigation of nucleolar protein localization (NBS1, TOPBP1).
- Evaluation of DNA damage markers in the nucleolus.
Main Results:
- Oxaliplatin inhibits rRNA transcription through ATM and ATR signaling.
- The drug causes nucleolar disruption and accumulation of NBS1 and TOPBP1.
- Transcriptional inhibition is independent of NBS1 and TOPBP1.
- Oxaliplatin does not induce significant direct DNA damage in the nucleolus.
Conclusions:
- Oxaliplatin triggers a unique ATM/ATR signaling pathway that suppresses Pol I transcription.
- This pathway operates independently of direct nucleolar DNA damage.
- The study highlights a distinct mechanism of nucleolar stress and transcriptional silencing linked to DNA damage signaling, contributing to platinum drug cytotoxicity.
More Related Videos
08:41Author Spotlight: Deciphering the Role of ATM in Ataxia-Telangiectasia and the Associated Cerebellar Degeneration
Published on: December 27, 2024
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
The Intrinsic Apoptotic Pathway
PI3K/mTOR/AKT Signaling Pathway
Restarting Stalled Replication Forks